Grup de recerca de biomarcadors en càncer (GReBiC)
- Nombre de publicacions
- 455
Publicacions
-
Bodtger, U; Porcel, JM; Bhatnagar, R; Munavvar, M; Jensen, C; Clementsen, PF; Rasmussen, DB
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Jove-Journal of Visualized Experiments -. .
-
Porcel, JM; Bielsa, S; Civit, C; Aujayeb, A; Janssen, J; Bodtger, U; Fjaellegaard, K; Petersen, JK; Welch, H; Symonds, J; Mitchell, MA; Grabczak, EM; Ellayeh, M; Addala, D; Wrightson, JM; Rahman, NM; Munavvar, M; Koegelenberg, CFN; Labarca, G; Mei, F; Maskell, N; Bhatnagar, R
Clinical characteristics of chylothorax: results from the International Collaborative Effusion database
ERJ Open Research 9 -. .
-
Polanco, D; Pinilla, L; Gracia-Lavedan, E; Gatius, S; Zuil, M; Pardina, M; Gomez, S; Barbe, F
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cancer patients
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 149 12459-12468. .
-
Porcel, JM; Sancho-Marquina, P; Monteagudo, P; Bielsa, S
Pleural effusion secondary to endometriosis: A systematic review
AMERICAN JOURNAL OF THE MEDICAL SCIENCES 366 296-304. .
-
O'Rourke, CJ; Salati, M; Rae, C; Carpino, G; Leslie, H; Pea, A; Prete, MG; Bonetti, LR; Amato, F; Montal, R; Upstill-Goddard, R; Nixon, C; Sanchon-Sanchez, P; Kunderfranco, P; Sia, D; Gaudio, E; Overi, D; Cascinu, S; Hogdall, D; Pugh, S; Domingo, E; Primrose, JN; Bridgewater, J; Spallanzani, A; Gelsomino, F; Llovet, JM; Calvisi, DF; Boulter, L; Caputo, F; Lleo, A; Jamieson, NB; Luppi, G; Dominici, M; Andersen, JB; Braconi, C
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Gut 73 496-508. .
-
Marqués M; Pont M; Hidalgo I; Sorolla MA; Parisi E; Salud A; Sorolla A; Porcel JM
MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .
-
Welch, H; Kerkhoff, J; Janssen, J; Bielsa, S; Civit, C; Porcel, J; Fjaellegaard, K; Petersen, J; Bodtger, U; Grabczak, E; Krenke, R; Ellayah, M; Addala, D; Hallifax, R; Wrightson, J; Rahman, N; Jackson, K; Pellas, E; Khan, I; Chohan, M; Aujayeb, A; Labarca, G; Dhaliwal, I; Mitchell, M; Rozman, A; Marc-Malovrh, M; Anevlavis, S; Foudrakis, M; White, P; Bhatnagar, R; Maskell, N
Clinical Characteristics of Non-Malignant Effusions: Results from the ERS International Collaborative Effusion (ICE) Database
EUROPEAN RESPIRATORY JOURNAL 62 -. .
-
Pont, M; Marques, M; Sorolla, MA; Parisi, E; Urdanibia, I; Morales, S; Salud, A; Sorolla, A
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
Cancers 15 -. .
-
Porcel, JM; Cordovilla, R; Tazi-Mezalek, R; Barrios-Barreto, D; Pérez-Pallarés, J; Bastos, HNE; Martínez-Tomás, R; Flandes-Aldeyturriaga, J; Cases-Viedma, E; Recalde, B; Botana-Rial, M
Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review
ARCHIVOS DE BRONCONEUMOLOGIA 59 566-574. .
-
Ost DE; Feller-Kopman DJ; Gonzalez AV; Grosu HB; Herth F; Mazzone P; Park JES; Porcel JM; Shojaee S; Tsiligianni I; Vachani A; Bernstein J; Branson R; Flume PA; Akdis CA; Kolb M; Portela EB; Smyth A
Reporting Standards for Diagnostic Testing: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals.
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY 30 207-222. .
-
Parisi, E; Hidalgo, I; Montal, R; Pallise, O; Tarragona, J; Sorolla, A; Novell, A; Campbell, K; Sorolla, MA; Casali, A; Salud, A
PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .
-
Schmid P; Cortes J; Joaquim A; Jañez NM; Morales S; Díaz-Redondo T; Blau S; Neven P; Lemieux J; García-Sáenz JÁ; Hart L; Biyukov T; Baktash N; Massey D; Burris HA 3rd; Rugo HS
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
BREAST CANCER RESEARCH 25 67-67. .
